DEA and Doctors: Cooperation for the Public Good
|
|
- Bertram Stokes
- 5 years ago
- Views:
Transcription
1 Addiction, Pain, & Public Health website - DEA and Doctors: Cooperation for the Public Good Asa Hutchinson, Administrator: Drug Enforcement Agency (DEA); Presentation to the American Pain Society (APS), Baltimore, Maryland; [Identifier: [Related resources: [Related resources: [See also: War on Drugs, War on Doctors, and the Pain Crisis in America; DeLuca; 2004] Good evening. Thank you, Dr. Ashburn, for that kind introduction and especially for the invitation to address the American Pain Society tonight. I have to first say what an inspiration it was to hear Coach Frank Layden speak. Frank-we do have a head coach opening in Arkansas! Coach's message on not quitting is a powerful one. It's a message that applies-not just in the sports arena, but also in our effort to combat drug abuse. Regrettably, there are those in our country who want to give up on our fight against illegal drugs. We are making significant progress in our fight against drugs. Drug use overall is down by 50 percent in the last 20 years. Cocaine use is down 75 percent in the last 15 years. That is progress. Success comes in many forms. It could be the teenager that chooses a drug-free life; it could be the professional athlete or doctor that overcomes an addiction problem; or it could be the arrest of a major trafficker. This is the job of the DEA: targeting those who traffic in illegal drugs and reducing that supply. But another critical responsibility-that you all are concerned about-is of course regulating the distribution of legal drugs to prevent their diversion into the illegal market. And it's great to be here with you tonight to talk about some challenges facing us in that area. The last time I was with some members of your organization was in the fall at our press conference releasing our joint statement on promoting pain relief and preventing abuse of pain medications. It was a historic moment for the DEA, the American Pain Society, and the 20 other health organizations that joined together in that consensus statement. It was important to give the American public a fuller understanding of how we are working to prevent that abuse while allowing its use for patients in need. It was critical that we let the public know law enforcement and the health community are working together. We are not at odds. We have a shared goal of making sure that controlled substances are used only for the health and welfare of the American public. We made a commitment at that press conference to achieving a balanced approach to the prescribing and regulating of opioids. My message to you tonight is that we stand by that commitment. And so I am pleased to be partnering with your organization, which has assumed national leadership in pain management. And I need to thank you again for the resolution you presented us in July recognizing the DEA's efforts to improve pain management. Tonight, I'd like to discuss tonight three topics. First, your concern for the effective treatment of
2 pain. Second, the DEA's concern about the diversion of legal drugs. And third, recent voter referendums setting medical standards. First, let s look at your mission of effectively treating your patients pain. You face many challenges in doing your job, and one of those that has captured the attention of the media, the Congress, and the American public is the under treatment of pain and the abuse of opioids. While OxyContin has probably received more publicity than any other abused legal drug, it is not of course the first time we ve seen this kind of problem. If we go back a century and look at the beginning of our drug abuse problems in this country, we learn that, by 1900, about one American in 200 was either a cocaine or opium addict. A great number of those had become addicted inadvertently through legal medicines. These were legal drugs then because science and experience had not yet taught us how dangerous those drugs are. But those dangers became evident and the new federal Pure Food and Drug Act of 1906 required manufacturers of patent medicines for the first time to reveal drug content. In this way, Americans learned which of its medicines contained heavy doses of cocaine and opiates-drugs they had now learned to avoid. In describing that time in our history, drug historian Jill Jones said, America was finally understanding the very real dangers of inadvertent addiction from medical treatment. Doctors and patients alike became more cautious, understanding the addictive qualities of these drugs. And so most people avoided these very powerful drugs that were increasingly proving to have little of their purported medical benefit, and only a lot of harmful effects. But what s interesting is what happened next. There were still people who wanted the drugs even knowing they weren t good medicine. According to Jones, there was now a whole new group of users who purposefully pursued the pleasurable sensation of the altered state. We have seen the same shift from unintentional use to recreational abuse to addiction. People who choose to abuse beneficial drugs like OxyContin to achieve a high. And so society and the medical and law enforcement community have been dealing with drug abuse for some time. Now it s OxyContin. And its abuse is a serious problem, one that the public and Congress and the DEA is very concerned about. When a state like Florida reports more deaths from OxyContin than from cocaine or heroin in the first 6 months of 2001, we become concerned. When the Drug Abuse Warning Network reports that mentions for oxycodone, the active ingredient in OxyContin, were more than 100 percent higher in 2000 than in 1998, we must be concerned. When, in a 6-month period, the Boston area experienced 36 robberies of pharmacies involving the forcible acquisition of stocked OxyContin supplies, our alarm increases. And, when we discover an organized ring of criminals in North Carolina who used computers to create forged prescriptions to divert thousands of dosage units of OxyContin to abusers, we must be vigilant to reducing abuse. And OxyContin is not the only drug that s diverted into the illegal market. Overall, the number of people who abuse prescription drugs each year roughly equals the number who abuse cocaineabout 2 to 4 percent of the population. In light of all this, I know the medical community has become somewhat wary about the use of OxyContin and other opioids. I know Dr. Ashburn told Congress that Fears of diversion and
3 regulatory scrutiny weigh heavily on the physician s mind when prescribing these medications. Other medical groups have expressed similar concerns to me. I m here to tell you that we trust your judgment. You know your patients. The DEA does not intend to play the role of doctor. Only a physician has the information and knowledge necessary to decide what is appropriate for the management of pain in a particular situation. The DEA is not here to dictate that to you. We do not intend to restrict legitimate use of OxyContin or other similar drugs. We will not prevent practitioners acting in the usual course of their medical practice from prescribing OxyContin for patients with legitimate medical needs. We never want to deny deserving patients access to drugs that relieve suffering and improve the quality of life. Let me tell you when the DEA investigates the diversion of controlled substance. We do not just randomly select doctors or pharmacists to investigate. The vast majority of the time-i d estimate about 90 percent, in fact, DEA is alerted to possible illegal activity through complaints from pharmacists, other doctors or nurses, family members, local law enforcement, or state authorities. There s a misperception that we judge wrongdoing on the part of a doctor solely on whether he or she is prescribing high quantities of drugs. In reality, quantity alone is not an indicator of wrongdoing. We may look at numbers as a possible indicator of suspicious activity, but in the absence of other information about diversion, quantity alone is not an indication of violation. The vast majority of doctors will never even see the DEA during their careers. In 2001, more than 900,000 physicians were registered with the DEA to handle controlled substances. During that year, we initiated only 861 investigations of physicians. We took 697 actions against violators, most of which were the surrender of DEA registrations for cause. This means the doctor was no longer entitled to a DEA number because they either were no longer licensed to practice medicine or were convicted of a drug-related felony. Given that only a very small percentage of physicians are investigated and sanctioned, and the fact these investigations are initiated in response to complaints, a physician acting in good faith and in accordance with established medical norms should be confident in their ability to prescribe appropriate pain medications. So let me give you an example of the kind of doctors we do investigate. Dr. Robert Weitzel was a physician in Utah who was brought to our attention through an anonymous complaint. It turned out Dr. Weitzel was providing patients with prescriptions for the Schedule II opioids Morphine and Demerol and requiring they return the drugs to him so he could administer partial quantities and keep the rest for his own use. He even picked up drugs himself at pharmacies that he issued in patients names without their knowledge. Many of these patients never received the medications, and some had never been treated by the doctor. Dr. Weitzel surrendered his DEA registration and pled guilty to obtaining drugs by fraud. And so that illustrates the kind of doctors the DEA is targeting. Those who unlawfully deliver controlled substances. And let me be clear that the DEA will take strong enforcement efforts against people like Dr. Weitzel who are diverting controlled substances and who are causing such great harm. And that brings me to the second topic I want to address tonight-the DEA s concern about diversion of drugs, particularly OxyContin. I mentioned the many abuse situations we re seeing.
4 So, in response to the escalating abuse and diversion of OxyContin, the DEA implemented a National Action Plan. This Plan concentrates on enforcement and regulatory investigations targeting key points of diversion, including forged and fraudulent prescriptions, doctor shoppers, and unscrupulous medical professionals. A few of the key things we re doing: We re encouraging the development of state prescription monitoring programs. We have found that states that have these programs in place have the lowest numbers of diversion problems. We re working with healthcare groups-by making presentations at conferences like this and publishing information to help practitioners better identify diversion scams and drugseeking behavior. We re emphasizing education. It s critical. And that effort must come from the medical community. It should include programs to increase practitioners knowledge regarding the appropriateness of opioid prescribing as well as the establishment of better clinical guidelines for the assessment of pain. We re communicating to the pharmaceutical industry our position on marketing and promotional activity. We believe disproportionate abuse of OxyContin may be partially due to aggressive marketing and promotion, particularly as a less abuseable substitute for a variety of less addictive medications. And so there are many ways we can work together as we seek a balanced approach between patient care and diversion prevention. The third and final topic I d like to address is referendum-based medical care: Voter initiatives that attempt to set medical standards for your profession. It is clear to me that we should not allow medical issues or determinations of a drug s valid medical use to be determined in a voting booth. Medical guidelines need to be based on the best available science undertaken by medical professionals. Several states have passed marijuana initiatives that allow doctors to prescribe marijuana for medical treatment. That s not the way it should be done. The DEA remains opposed to that, which is a position that may not be popular with some. In fact, I know it s not. I was in San Francisco last month delivering a speech to the Commonwealth Club of California. When the pro-medical marijuana crowd got wind that I d be there, they organized a protest and had over 200 people including the district attorney and two members of the Board of Supervisors marching outside. Many of them came inside and heckled me while I was speaking. They strongly disagreed with the DEA s position that marijuana is not medicine, and weren t shy in letting me know that. But we came to that decision because we listen to science. What the science has told us thus far is that there is no medical benefit from smoking marijuana. It is not recommended for the treatment of any disease. In fact, the research has shown that it can do more harm than good in people with already compromised immune systems. A study out just last week shows that long-term marijuana-smoking impairs brain function. However, we at the DEA realize how important it is to keep listening to science. And that s why we ve authorized studies with smoked marijuana in humans. Under a program
5 established by the state of California, two researchers at the University of California San Diego are studying the safety and efficacy of cannabis compounds in humans as an alternative for treating certain debilitating medical conditions. Another voter referendum that you all are familiar with is Oregon s Death with Dignity Act that was passed a few years back and allows doctors to prescribe drugs to end a patient s life. I know some in the medical community are concerned about physician-assisted suicide and the Attorney General s recent position on Oregon s law. It s a sensitive subject. The central point in our position is that the American public must be confident that controlled drugs are used for legitimate medical purposes and will cause no undue harm to patients. And that is why the DEA has determined that drugs controlled by federal law may not be legally dispensed to assist suicide. You should know DEA s position has been challenged by the State of Oregon and is currently the subject of litigation in Federal court. Please be assured that the DEA understands your responsibility to pain sufferers and those seeking to diminish their suffering. Physicians should not hesitate to prescribe suitable medications for pain relief, even if dosages to properly control pain entail the risk of hastening death. You should feel confident in your ability to provide appropriate pain medications to those in the last stages of life. Please know that we at the Department of Justice realize that pain management is good medical care. Thank you for your leadership. With groups like yours who are on the forefront of treating pain and who are such important advocates for the people you care for, I know we will succeed. Mother Teresa was once asked how she was able to minister to so many thousands of sick and dying people. Her simple answer was, One at a time. And so, you too are doing that same thing. When you identify appropriate pain treatment for a patient and help them heal and resume normal activities, you are restoring their lives. One at a time, you are finding that balance between promoting pain management and preventing abuse. That s success, and I look forward to working with you as we continue to achieve that success together. Thank you. [END]
9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort
DEA FIELD OFFICES IN FLORIDA Miami Divisional Office David Wickey, GS 954-306-4650 Orlando District Office Linda Stocum, GS 407-333-7046 Tampa District Office Amie Hickerson, GS 813-287-5160 Tallahassee/Jacksonville
More informationPrescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.
How serious a public health problem in the State of New York is each of the following: [Q1A-Q1I ROTATED] Q1A. Alcohol abuse Very serious 61% 63% 53% 63% 36% 71% 52% Somewhat serious 35% 35% 38% 33% 52%
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationOXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003
OXYCONTIN Diversion & Abuse Office of Diversion Control October 2003 OXYCONTIN OxyContin is a controlled release form of Schedule II oxycodone Manufactured in tablet form and intended for oral ingestion
More informationSWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective
SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective I am a federal prosecutor in Seattle, Washington. Within the last two years, I
More informationIowa District Court Polk County, Iowa. CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV IOWA BOARD OF PHARMACY ) ) Respondent.
Iowa District Court Polk County, Iowa CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV 51068 IOWA BOARD OF PHARMACY ) ) Respondent. ) MEMORANDUM IN SUPPORT OF PETITION FOR JUDICIAL REVIEW Federal
More informationConversations With. The Honorable Dick Thornburgh The Honorable Rudolph W. Giuliani. The Issue: Prescription Drug Abuse
Conversations With The Honorable Dick Thornburgh The Honorable Rudolph W. Giuliani WINTER 2005 The Issue: Prescription Drug Abuse In this edition of Washington Legal Foundation's CONVERSATIONS WITH, former
More informationPennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
More informationPrescription Drug Take-Back Program Q s and A s
Got Drugs? Prescription Drug Take-Back Program Q s and A s What is the national drug take-back day? On Saturday, September 25 from 10:00 a.m. to 2:00 p.m., DEA and partner organizations will set up sites
More informationTHE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and
THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing
More informationMedical marijuana or employment - a tough decision for some
Medical marijuana or employment - a tough decision for some Published: Thursday, October 06, 2011 By SEAN DEALTON For The Oakland Press Of the more than 100,000 registered medical marijuana-using patients
More informationPrescription Monitoring Program: Law Enforcement Responsibilities National Conference of State Legislatures
Prescription Monitoring Program: Law Enforcement Responsibilities National Conference of State Legislatures Columbus, Ohio October 12, 2007 WARREN COUNTY DRUG TASK FORCE DENNIS M. LUKEN, DETECTIVE P.O.
More informationCMA Response: Health Canada s Medical Marihuana Regulatory Proposal. Submitted to the Office of Controlled Substances Health Canada.
CMA Response: Health Canada s Medical Marihuana Regulatory Proposal Submitted to the Office of Controlled Substances Health Canada February 28, 2013 A healthy population and a vibrant medical profession
More informationMANAGING MEDICAL & RECREATIONAL CANNABIS IN THE WORKPLACE
MANAGING MEDICAL & RECREATIONAL CANNABIS IN THE WORKPLACE 1 CONTENTS While medical cannabis has been legal for some time, on October 17, 2018, recreational cannabis became legal in Canada. This rapid change
More informationPatient and Family Agreement on Opioids
Patient and Family Agreement on Opioids We care about our patients and are committed to their recovery and wellness. We offer our patients medications and options for various services to keep them from
More informationSeptember 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic
National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationUpdate on the Opioid Crisis
Update on the Opioid Crisis Robert A. Alldredge Jr Fort Worth Police Deputy Chief Homer Robertson Fort Worth Fire Department Assistant Chief Chris Mosley Sr. Assistant City Attorney/Section Chief Opioid
More informationStatement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.
Statement Of The National Association of Chain Drug Stores For United States Senate Caucus on International Narcotics Control Hearing on: Improving Management 10:00 a.m. 226 Dirksen Senate Office Building
More informationRESOLUTION OF THE BOARD OF SUPERVISORS OF THE COUNTY OF SAN DIEGO DECLARING MARCH AS PRESCRIPTION DRUG ABUSE AWARENESS MONTH
Resolution No. 14-031 Meeting Date: 03/11/2014 (29) RESOLUTION OF THE BOARD OF SUPERVISORS OF THE COUNTY OF SAN DIEGO DECLARING MARCH AS PRESCRIPTION DRUG ABUSE AWARENESS MONTH WHEREAS, More deaths were
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationFoster Dennin Page 1 AP Lang 3/1/17 Research Paper Recreational Marijuana: Yes or No?
Foster Dennin Page 1 AP Lang 3/1/17 Research Paper Recreational Marijuana: Yes or No? Medical marijuana is a topic that needs to be discussed more in our current society. In my paper I am trying to get
More informationWe are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit
We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit Objectives Provide a background of the law enforcement initiative with the current heroin problem and how we
More informationBREAKING THE CYCLE T H E O P I O I D E P I D E M I C I N A M E R I C A
BREAKING THE CYCLE T H E O P I O I D E P I D E M I C I N A M E R I C A OVERVIEW Across the United States, about 90 people die per day due to opioid overdoses, which equates to every three in five overdose
More informationKansas Sheriffs Association PO Box 1122 Pittsburg, KS (620)
Kansas Association of Chiefs of Police PO Box 780603 Wichita, KS 67278 (316)733-7300 Kansas Sheriffs Association PO Box 1122 Pittsburg, KS 66762 (620)230-0864 Kansas Peace Officers Association PO Box 2592
More informationAttitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.
Running Head: MEDICATION-ASSISTED TREATMENT ATTITUDES Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program Caroline Allison Dr. Kathleen Moore, Ph.D. Department of Mental Health Law
More informationNational Council on Patient Information and Education
National Council on Patient Information and Education You are not alone The type of pain that caused your doctor to prescribe a pain medicine for you can make you feel that you are different from everyone
More informationTable of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004
OXYCONTIN TASK FORCE INTERIM REPORT January 30, 2004 Submitted to Hon. Elizabeth Marshall, Minister of Health & Community Services, Government of Newfoundland and Labrador Table of Contents INTRODUCTION
More informationFAQ: Alcohol and Drug Treatments
Question 1: Are DUI offenders the most prevalent of those who are under the influence of alcohol? Answer 1: Those charged with driving under the influence do comprise a significant portion of those offenders
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationResearch: Medical Cannabis
Research: Medical Cannabis Background The hemp plant Cannabis sativa (cannabis) is commonly known as marijuana and can be used as a therapy to alleviate symptoms such as pain and fatigue caused by chronic
More informationPrescription Drug Abuse Task Force Rx Report Card
San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationThe Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose
The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose 1 Learning Objectives Identify pain treatment related regulatory agencies Discuss the changing role of regulatory
More information9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A
Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin
More informationLaw Enforcement and the Prescriber Enforcement Action Protocol
Law Enforcement and the Prescriber Enforcement Action Protocol Ken Clark U.S. Department of Justice United States Attorney s Office District of Maryland Opioid Abuse Approx 2.6 fatal overdoses per day
More informationWhich was the greatest problem with patent medicines in early America that lead to drug legislation?
Pharmacology Connections to Nursing Practice 3rd Edition Adams Test Bank Full Download: http://testbanklive.com/download/pharmacology-connections-to-nursing-practice-3rd-edition-adams-test-bank/ Adams
More informationUniversity of Pittsburgh
Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationThank you very much for spending some time with us today to learn about a very important health problem in the United States.
Thank you very much for spending some time with us today to learn about a very important health problem in the United States. I'm going to spend the next 20 to 30 minutes chatting with you about a life
More informationOpioid Addiction Statistics
May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationsome things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment
some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment This booklet was created to help you learn about opioids. You probably have lots
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More information50 % They don t just get drunk every month, they get drunk and/or use drugs. NOT MY KID NOT MY PRACTICE. College Headline 4/2/2013. Robert M.
NOT MY KID NOT MY PRACTICE 68% of high school graduates said that drugs played a major role in their lives. 22% of parents said that drugs played a major role in their children s lives. Robert M. Stutman
More informationClearing Up The Confusion About Substance Abuse Testing
Clearing Up The Confusion About Substance Abuse Testing 2018 Indiana Safety and Health Conference and Expo Presented by Tiffany Ellefson, DISA/Midwest Toxicology Services Items to cover Latest Trends in
More informationEducating Courts, Other Government Agencies and Employers About Methadone May 2009
Educating Courts, Other Government Agencies and Employers About Methadone May 2009 The judge said that I won t get my kids back unless I withdraw from methadone. Is that legal? My Probation Officer instructed
More informationhelping military veterans improve their quality of life through access to cannabis for medical purposes.
The Cannabis cure DAV calls for more research into medical cannabis as an alternative pain relief option for veterans with chronic pain, PTSD and TBIs Like many veterans, the rigors of military service
More informationRaid Preparedness for Medical Marijuana Dispensaries. Written by Cannabis Training University (CTU) All rights reserved
Raid Preparedness for Medical Marijuana Dispensaries Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 How to Handle a Raid on a Medical Marijuana Dispensary...
More informationFACING ADDICTION OVER DINNER
FACING ADDICTION OVER DINNER The NATIONAL NIGHT of CONVERSATION November 17, 2016 The dinner table is one of the most important places in the house for improving the health of your family, but not only
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationMEDICAL MARIJUANA USE
AOM Chapter P-158 MEDICAL MARIJUANA USE GENERAL CONSIDERATIONS AND GUIDELINES: Massachusetts voters decided that this Commonwealth should join a growing number of other states that currently have laws
More informationDrug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum
Drug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum Ohio SOPHE Health Educators Institute October 27, 2017 Kevin Lorson HOPECurriculum@wright.edu Today s Goals: 1. Describe prevention
More informationChairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and
United States House of Representatives Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade Hearing on Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield
More informationMissouri Guidelines for the Use of Controlled Substances for the Treatment of Pain
Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This
More informationPrescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality. Brad Schimel Wisconsin Attorney General
Prescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality Brad Schimel Wisconsin Attorney General Small Print I am not a medical or treatment expert I do not know how best to treat chronic pain
More informationWhat Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1
June 2017 1 2 What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1 Mark R. Hayes, Director of Legal Services, and Lanny Richmond II, Staff Attorney Introduction In 2016, the
More informationOpioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
More informationWork Session VIII: Legalized Marijuana. Douglas J. Friednash City Attorney Denver, Colorado
Work Session VIII: Legalized Marijuana Douglas J. Friednash City Attorney Denver, Colorado 2013 International Municipal Lawyers Association. This is an informational and educational report distributed
More informationMaine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014
Maine s Medical Marijuana Law 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000) Delaware
More informationRosenthal Center for Addiction Studies. Survey on Perceptions of Drug Use in America
Rosenthal Center for Addiction Studies Survey on Perceptions of Drug Use in America December 14, 2016 1 Table of Contents Introduction...3 Executive Summary...6 Drug Use in the Family... 16 Childhood Drug
More informationDeciphering Chronic Pain and Pain Medicine
Deciphering Chronic Pain and Pain Medicine Deciphering Chronic Pain and Pain Medicine Hello and welcome to Primary Care Today on ReachMD. I m your host, Dr. Brian McDonough, and I m very happy to have
More informationAHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion
Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,
More informationTobacco-Free School Enforcement Guidelines
Tobacco-Free School Enforcement Guidelines Some of the most frequently asked questions about a tobacco-free school policy concern enforcement. Experience shows that policies that are clearly communicated
More informationAppearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse
Opening Statement Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse Dr. Chris Simpson, President-elect
More informationLast night his childhood was kissed, fondled and violated goodbye.
Help Hope Healing One in four girls and one in six boys experience something so horrible before the age of 18 that many of them wait decades to tell anyone about it. Look at the children in your life.
More informationDear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good
PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion
More informationSafe Medication Practices
Safe medication practices for life. Slide 1 Safe Medication Practices Facilitator Talking Points Welcome to today s program, Generation Rx: Safe Medication Practices for Life. You may be asking yourself,
More informationADAPTING YOUR COURT STRUCTURE
ADAPTING YOUR COURT STRUCTURE Developed by: National Drug Court Institute NDCI, March 2018 The following presentation may not be copied in whole or in part without the written permission of the author
More informationSeeing through the Smoke: Preparing Your Workplace for Legalized Marijuana. October 23, 2018
Seeing through the Smoke: Preparing Your Workplace for Legalized Marijuana October 23, 2018 Let s Be Blunt... With the many new state laws being passed legalizing medical and recreational marijuana, employers
More informationRhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMike s Blog School of Government, UNC-Chapel Hill
The Opioid Crisis Author : Mike Smith Categories : Uncategorized Date : June 15, 2017 Jill Moore asked me to introduce Attorney General Josh Stein as the kick-off speaker for last week s Local Health Directors
More informationPresentation Overview
Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective
More informationOHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:
Cuyahoga County Board of Health OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: NOVEMBER 5, 2014 CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements
More informationCHANGING THE PARADIGM FOR OPIOID PRESCRIBING. Kim Swanson, Ph.D. Chair Pain Standards Task Force
CHANGING THE PARADIGM FOR OPIOID PRESCRIBING Kim Swanson, Ph.D. Chair Pain Standards Task Force Acknowledgements Central Oregon Health Council Pain Standards Task Force PacificSource Community Solutions
More informationTeaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic
Preventing Controlled Substance Diversion David B. Brushwood, R.Ph.,., J.D. Professor of Pharmaceutical Outcomes & Policy The University of Florida Teaching Objectives Describe the balance a that must
More informationMarijuana strains doctor-patient relationship Jcamilobernal/iStock/Thinkstock
Early release, published at www.cmaj.ca on August 25, 2014. Subject to revision. Marijuana strains doctor-patient relationship Jcamilobernal/iStock/Thinkstock Medical marijuana is plainly bad medicine,
More informationDEA: Combating the Supply
Drug Enforcement Administration DEA: Combating the Supply 2nd Annual Opioid Abuse and Heroin Overdose Solutions Summit Cathy Gallagher Diversion Program Manager Detroit Division May 11, 2017 1 Prescription
More informationISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.
Code of New Mexico Rules Title 16. Occupational and Professional Licensing Chapter 17. Osteopathic Medicine and Surgery Practitioners Part 5. Prescribing and Distribution of Controlled Substances 16.17.5.
More informationSubstance Prevention
First Name Last Name Period Substance Prevention POINTS ASSIGNMENT /65 pts Worksheet Total /10 pts Book Activity Page /10 pts Group Discussion on Substance Use in Teenagers /10 pts Teenage Drinking Brain
More information4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
More informationFAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009
FAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009 Introduction The NATA considers the Joint Statement on Cooperation a very positive resolution
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More informationADDITIONAL CASEWORK STRATEGIES
ADDITIONAL CASEWORK STRATEGIES A. STRATEGIES TO EXPLORE MOTIVATION THE MIRACLE QUESTION The Miracle Question can be used to elicit clients goals and needs for his/her family. Asking this question begins
More informationChanging the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 TITLE: Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol
More informationMethadone Grows as Killer Drug
February 9, 2003 Methadone Grows as Killer Drug By PAM BELLUCK ORTLAND, Me. Methadone, a drug long valued for treating heroin addiction and for soothing chronic pain, is increasingly being abused by recreational
More informationStrategic Plan
2017-18 Strategic Plan 1 Strategic Planning Process The Summit County Opiate Task Force has made great strides in addressing the opiate crisis in the last few years. More than 100 Summit County citizens
More informationDrug Use Around the World
Special Agents U.S. DRUG ENFORCEMENT AGENCY STAFFING AND BUDGETS 1975 2000 10000 5000 Total Employees 8000 6000 4000 3000 2000 4000 1975 1980 1985 1990 1995 2000 1000 1975 1980 1985 1990 1995 2000 Support
More informationHow Ofsted regulate childcare
Information for parents about Ofsted s role in regulating childcare This section provides information about how Ofsted regulates childcare providers. It sets out how you might like to use the information
More informationImplementation: Public Hearing: Request for Comments (FDA-2017-N-6502)
March 16, 2018 via online submission: www.regulations.gov The Honorable Scott Gottlieb Commissioner Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Opioid Policy Steering
More informationTAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT
TAXOTERE: WHAT YOU NEED TO KNOW ABOUT IT 1 Fighting breast cancer is a very emotional battle for women. Doctors are trying to save the lives of women by trying new and innovative methods and drugs. One
More informationTEEN EDUCATION. Medication Safety for Teens.
Slide 1 Welcome to today s program, My Generation Rx: Medication Safety for Teens. You may be asking yourself, What is My Generation Rx? My Generation Rx encourages teens to incorporate the Generation
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationSULLIVAN COUNTY Drug Abuse Prevention Task Force
SULLIVAN COUNTY Drug Abuse Prevention Task Force Joseph A. Todora LMSW, Commissioner Sullivan County Division of Health ans Family Servies 17 Community Lane Liberty, NY 12754 MISSION: The mission of the
More informationEmployee Education Working Partners
Employee Education Working Partners for an Alcohol- and Drug-Free Workplace Provided by the Department of Human Resources Management Mississippi State University Employee Education Outline Objectives of
More informationDeveloping a Public Education Campaign on Prescription Opiates. Samantha Kaan, MPH Multnomah County Health Department April 24, 2015
Developing a Public Education Campaign on Prescription Opiates Samantha Kaan, MPH Multnomah County Health Department April 24, 2015 Desired Outcomes// What I hope you will get out of this Understand the
More informationDrug Epidemics: Things You Need to Know. Prof. Carl L. Hart Columbia University. drcarlhart.com
Drug Epidemics: Things You Need to Know Prof. Carl L. Hart Columbia University drcarlhart.com 10 MA vs. $20 Choice (max =10) 8 6 4 2 drug users can and do behave rationally 0 Drug Money Reinforcer Things
More information